Trials / Sponsors / Susan Chi, MD
Susan Chi, MD
Academic / Other · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors Atypical Teratoid Rhabdoid Tumor, INI1 (SMARCB1)-Deficient Primary CNS Malignant Tumors, SMARCA4-deficient Primary CNS Malignant Tumors | Phase 1 / Phase 2 | 2023-08-10 |